Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
is a suitable target for biocatalytic oxidation
GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes
compared with the 4-week Teriparatide administration + 8-week vehicle administration
InChi: InChI=1S/C40H49N5O14S/c41-44-42-8-12-52-16-20-56-21-17-53-13-9-45(10-14-54-18-22-57-24-23-55-19-15-51-11-7-37(48)49)39(60)43-28-1-4-32-31(25-28)38(50)59-40(32)33-5-2-29(46)26-35(33)58-36-27-30(47)3-6-34(36)40/h1-6
or 300 mg/kg twice per week in subcutaneous xenografts of KARPAS-422 and Pfeiffer cells
4-(2, 4, 4-Trimethylpentan-2-yl)benzene-PEG4-OH l (Z)- is a suitable target for4 (2,4,4 Trimethylpentan 2 yl)benzene PEG4 OH, a nonionic surfactant with a low hydrophile lypophile balance (HLB) value and dispersible in aqueous solution at room temperature, has a Krafft point above the room temperature. 4 (2,4,4 Trimethylpentan 2 yl)benzene PEG4 OH has the potential for the research of the hepatitis C virus (HCV). Product information CAS Number: 2315 63 1 Molecular Weight: 382. 53 Formula: C22H38O5 Chemical Name: 2 [2 (2 {2 [4
US$ 225.00
US$ 290.00
US$ 275.00
US$ 750.00
US$ 445.00
US$ 400.00
US$ 300.00
US$ 255.00
US$ 510.00
US$ 445.00